Lemtrada® (Alemtuzumab) IV Infusion Therapy

Disease-Modifying Therapy for Relapsing Multiple Sclerosis

Clearwell Infusion Centers offers expert administration of Lemtrada (alemtuzumab) for adults with relapsing forms of multiple sclerosis (MS). Our Miami center provides private infusion suites, personalized care, and full clinical coordination for patients undergoing this high-impact disease-modifying therapy.

What Is Lemtrada?

Lemtrada® (alemtuzumab) is an FDA-approved monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in adults who have had an inadequate response to two or more MS therapies.

It works by targeting and depleting CD52-positive immune cells, which are believed to play a role in the inflammation and nerve damage seen in MS. The result is a long-term reduction in disease activity and relapses.

Lemtrada is administered as an IV infusion over five consecutive days for the first course, followed by a second course of three infusions one year later. No continuous infusions are required after that, though long-term monitoring is essential.

Learn more at the official Lemtrada website.

Who Is Lemtrada For?

Lemtrada is intended for adult patients with:

• Relapsing forms of MS
• Inadequate response to two or more prior MS medications
• No history of autoimmune kidney disease or serious heart or infection risks

Due to its safety profile, Lemtrada is reserved for individuals whose MS is active and not well controlled with other therapies.

Lemtrada Side Effects

Because Lemtrada affects the immune system, it carries a Risk Evaluation and Mitigation Strategy (REMS) and requires ongoing lab monitoring for at least 48 months after the last dose.

Common side effects include:

• Rash
• Headache
• Fever
• Nausea
• Infusion-related reactions (up to 90% of patients)

Serious risks include autoimmune conditions (e.g., thyroid disorders, kidney issues), infections, and increased risk of some cancers. Premedication and post-infusion observation protocols are strictly followed.

For full safety information, visit the Lemtrada safety guide.

Why Choose Clearwell for Your Lemtrada Infusion?

Clearwell Infusion Centers in Miami is designed for safe, comfortable, and highly-monitored biologic therapy. For Lemtrada patients, we provide:

• Private treatment suites with spa-like amenities
• Low patient-to-nurse ratio for attentive care
• Flexible appointment times, including weekends and evenings
• Comprehensive insurance coordination, including prior authorizations and benefits checks
• ACHC-accredited facility and safety standards
• Close coordination with your prescribing provider and care team

Our experienced infusion staff follows strict monitoring protocols before, during, and after each course of Lemtrada treatment.

Getting Started with Lemtrada Therapy

If your neurologist has prescribed Lemtrada, Clearwell will help coordinate every aspect of your care. From insurance approval and REMS enrollment to lab monitoring and scheduling, our team is here to support you.

Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers partners with neurologists and MS specialists to safely administer Lemtrada in a comfortable outpatient setting.

Why refer your patients to Clearwell?

• Full support with REMS program and lab tracking
• Same-week scheduling and pre-treatment prep
• Real-time communication and post-infusion updates
• Strict adherence to FDA protocols for Lemtrada
• ACHC-accredited facility and trained clinical staff

To refer a patient for Lemtrada infusion in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Looking to start your Lemtrada treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you